Documento de consenso GESIDA/GESITRA-SEIMC, SPNS y ONT sobre trasplante de órgano sólido en pacientes infectados por el VIH en España (marzo 2005) (original) (raw)

2005, … y Microbiología Clínica

Europe over the last five years has shown that three-year survival of these patients following organ transplantation is similar to that of HIV-negative patients. The consensus criteria for the selection of HIV patients for transplantation include the following: no opportunistic infections (except tuberculosis, esophageal candidiasis or Pneumocystis jiroveci -previously carinii -pneumonia), CD4 lymphocyte count above 200 cells/l (100 cells/l in the case of liver transplantation) and HIV viral load that is undetectable or suppressible with antiretroviral therapy. Also required is a two-year abstinence from heroin and cocaine, although the patient may be in a methadone program. The main problems in the post-transplantation period in these patients are pharmacokinetic and pharmacodynamic interactions between antiretorivirals and immunosuppressors, rejection, and the fact that the risk of relapsed HCV infection is exacerbated, and this is one of the main causes of post-liver transplantation mortality. To date, the experience with pegylated interferon and ribavirin is limited in this population. The English version of the manuscript is available at http://www.gesidaseimc.com. Palabras clave: Trasplante de órgano sólido. Trasplante hepático. Trasplante renal. Trasplante cardíaco. Infección por el VIH. Infección por el VHC. Infección por el VHB, España. Al final del artículo se ofrece la relación de los miembros del Grupo de Trabajo de TOS en VIH en España. Enferm Infecc Microbiol Clin 2005;23(6):353-62 353

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact